2nd Quarter - Report

THE METROHEALTH SYSTEM for THE METROHEALTH SYSTEM

Firm
Client
Income
—
Expenses
$210,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Funding for drug therapeutic infusion pumps; H.R. 5371, the Continuing Appropriations and Extensions Act, 2026.

LobbyistCovered position, as disclosed
KINSEY JOLLIFF —
ALLISON POULIOS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5371 (119th)

Pharmacy PHA

H.R. 5256, the 340B ACCESS Act.

LobbyistCovered position, as disclosed
KINSEY JOLLIFF —
ALLISON POULIOS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5256 (119th)

Defense DEF

FY 2027 National Defense Authorization Act.

LobbyistCovered position, as disclosed
KINSEY JOLLIFF —
ALLISON POULIOS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Medicaid State Directed Payments; 340B modernization; funding for Disproportionate Share Hospitals (Medicaid DSH); funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; impact of regional oversaturation of trauma care on patient outcomes and health system costs; H.R. 4313/S. 2237, Hospital Inpatient Services Modernization Act; H.R. 267, the Health Care Price Transparency Act; H.R. 2590/S. 1264, the Mental and Physical Health Care Comorbidities Act of 2025; H.R. 8375/S. 4384, Medicare Advantage Improvement Act of 2026.

LobbyistCovered position, as disclosed
KINSEY JOLLIFF —
ALLISON POULIOS —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: S. 1264 (119th), H.R. 8375 (119th), H.R. 4313 (119th), H.R. 2590 (119th), S. 4384 (119th), S. 2237 (119th), H.R. 267 (119th)

Health Issues HCR

Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B modernization; impact of regional oversaturation of trauma care on patient outcomes and health system costs; Pandemic and All Hazards Preparedness Act reauthorization; H.R. 267, the Health care PRICE Transparency Act; H.R. 5256, the 340B ACCESS Act; H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025; H.R. 7279/S. 3707, Nurse Faculty Shortage Reduction Act of 2026.

LobbyistCovered position, as disclosed
KINSEY JOLLIFF —
ALLISON POULIOS —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 267 (119th), H.R. 5256 (119th), H.R. 7279 (119th), H.R. 4392 (119th), S. 3707 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.